Label UNT Conférences
le (23m51s)
Résultats de recherche
Trier par :
Nombre de programmes trouvés : 84
Conférences
le (2h22m30s)
9 - Vers un monde avec drogues ?
... des drogues en Colorado, Uruguay, Hollande » François-Georges Lavacquerie, porte-parole du CIRC (Collectif d’Information et de Recherche Cannabique) : « Sortir de la prohibition, réguler la production, le commerce et la consommation du cannabis »... Voir la vidéo
Label UNT Conférences
le (17m44s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Omics research and system biology. Keys for future personalized medicine How future trials may help optimizing benefit-to-risk ratio. The role of specialist scientific organizations.
... should no longer approve drugs for a heterogeneous broad population, but for a well defined sub-population where we can demonstrate a marked benefit”Dr. Stephen Grant, Deputy Director, Division of Cardiovascular Renal Products, CDER- “Regulatory bodies... Voir la vidéo
Label UNT Conférences
le (41m46s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : debate Omics research and system biology. Keys for future personalized medicine How future trials may help optimizing benefit-to-risk ratio. The role of specialist scientific organizations.
... from the use of these important agents in the wrong patient groups.”Juan Carlos Kaski, Cardiovasc Drugs Ther, 2012Réalisation, production : Canal U/3S et CERIMESKeyword : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention,... Voir la vidéo
Label UNT Conférences
le (36m52s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : The role of biomarkers
... prevent unnecessary complications that might derive from the use of these important agents in the wrong patient groups.”Juan Carlos Kaski, Cardiovasc Drugs Ther, 2012Réalisation, production : Canal U/3S et CERIMESKeyword : Cardiovascular Clinical... Voir la vidéo
Label UNT Conférences
le (4m38s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Journal editor’s viewpoints
... important agents in the wrong patient groups.”Juan Carlos Kaski, Cardiovasc Drugs Ther, 2012Réalisation, production : Canal U/3S et CERIMESKeyword : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, ISCP... Voir la vidéo
Conférences
le (29m46s)
Session 1 — Historiciser la ville néolibérale - The Color of War: Race, Neoliberalism and Punishment in late Twentieth Century Los Angeles
Donna Murch — Rutgers University The Color of War: Race, Neoliberalism and Punishment in Late Twentieth Century Los Angeles[La couleur de la guerre : la question raciale, le néolibéralisme et les sanctions pénales à Los Angeles à la fin du xxe siècle] Voir la vidéo
Label UNT Conférences
le (13m33s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Omics research and system biology. Keys for future personalized medicine How future trials may help optimizing benefit-to-risk ratio. The role of specialist scientific organizations.
... disease and we should no longer approve drugs for a heterogeneous broad population, but for a well defined sub-population where we can demonstrate a marked benefit”Dr. Stephen Grant, Deputy Director, Division of Cardiovascular Renal Products, CDER-... Voir la vidéo
Label UNT Conférences
le (13m19s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Journal editor’s viewpoints
... of the new anticoagulants. Together we should prevent unnecessary complications that might derive from the use of these important agents in the wrong patient groups.”Juan Carlos Kaski, Cardiovasc Drugs Ther, 2012Réalisation, production : Canal U/3S et... Voir la vidéo
Conférences
le (18m24s)
